Knoll Capital Management, LLC
MIAMI, FL · CIK 1325083 · 13F filing filed 2024-05-15
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
$160.7m
reported value
+33.1% vs Q4 2023
34positions
76.3%in top 10
5 new
5 added
1 reduced
3 sold out
vs Q4 2023
Holdings, Q1 2024
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| APPLIED THERAPEUTICS INC APLT | $37.9m23.58% | Added +100.0k |
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $26.8m16.69% | Unchanged |
| ALDEYRA THERAPEUTICS INC ALDX | $17.9m11.14% | Unchanged |
| AVADEL PHARMACEUTICALS PLC SPONSORED ADR | $10.1m6.30% | Unchanged |
| SPDR GOLD TR GLD | $6.6m4.10% | New |
| ENTERA BIO LTD ENTX | $6.5m4.03% | Unchanged |
| ALTIMMUNE INC ALT | $5.8m3.59% | Added +367.2k |
| HOOKIPA PHARMA INC COM | $3.9m2.44% | Unchanged |
| SEABRIDGE GOLD INC COM | $3.7m2.32% | Unchanged |
| EQUINOX GOLD CORP EQX | $3.3m2.06% | Added +129.9k |
| AGNICO EAGLE MINES LTD AEM | $3.3m2.06% | Unchanged |
| VERONA PHARMA PLC VRNA | $3.2m2.00% | Unchanged |
| SILVERCREST METALS INC SIL | $3.1m1.95% | Unchanged |
| FRANCO NEV CORP FNV | $3.0m1.85% | New |
| MAG SILVER CORP MAG | $2.9m1.81% | Added +170.0k |
| WHEATON PRECIOUS METALS CORP WPM | $2.8m1.76% | Unchanged |
| KINROSS GOLD CORP KGC | $2.7m1.68% | Unchanged |
| BOOZ ALLEN HAMILTON HLDG COR BAH | $1.9m1.20% | Unchanged |
| OCULAR THERAPEUTIX INC OCUL | $1.8m1.13% | Unchanged |
| VISA INC V | $1.4m0.84% | Unchanged |
| GLOBAL X FDS SIL | $1.2m0.77% | Reduced -130.8k |
| ALAMOS GOLD INC NEW AGI | $1.2m0.73% | Unchanged |
| CVS HEALTH CORP CVS | $1.2m0.72% | Unchanged |
| ISHARES SILVER TR SLV | $1.1m0.69% | New |
| NORTHROP GRUMMAN CORP NOC | $1.0m0.64% | Unchanged |
| ISHARES TR ITA | $1.0m0.63% | Unchanged |
| DIAGEO PLC DEO | $1.0m0.62% | New |
| ROYAL GOLD INC RGLD | $919.7k0.57% | Unchanged |
| PHILIP MORRIS INTL INC PM | $916.2k0.57% | Unchanged |
| MEREO BIOPHARMA GROUP PLC MREO | $859.6k0.53% | Added +100.0k |
| NEW PAC METALS CORP NEWP | $649.9k0.40% | Unchanged |
| Orgenesis, Inc. COM | $521.8k0.32% | Unchanged |
| OPUS GENETICS INC IRD | $201.0k0.13% | Unchanged |
| SKEENA RES LTD NEW SKE | $179.2k0.11% | New |
Sold out since Q4 2023
| Security | Value then |
|---|---|
| VANECK ETF TRUST GDX | $2.8m91.8k shares |
| VANECK ETF TRUST GDXJ | $2.0m53.1k shares |
| THERMO FISHER SCIENTIFIC INC TMO | $1.1m2.1k shares |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 | 5.3%≈ $4.7m |